Cambio - Excellence in Molecular Biology

Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen's products are hazardous and may be subject to additional shipping charges. Full product information is available on Glen Research's website.

Cholesteryl-TEG Phosphoramidite

Cholesteryl-TEG Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
40-4250-10optional diluent 10% THF in Anhydrous Acetonitrile20ml £0.00 Quantity Add to Order
10-1975-02Cholesteryl-TEG Phosphoramidite 0.25g £532.00 Quantity Add to Order
10-1975-90Cholesteryl-TEG Phosphoramidite 100µmoles £268.00 Quantity Add to Order
10-1975-95Cholesteryl-TEG Phosphoramidite 50µmoles £150.00 Quantity Add to Order

Description

Cholesteryl-TEG Phosphoramidite
 

Diluent: 10% THF in Anhydrous Acetonitrile  40-4250-10- Please request with your order if required.

Catalog Number: 10-1975-xx

Description: Cholesteryl-TEG Phosphoramidite

1-Dimethoxytrityloxy-3-O-(N-cholesteryl-3-aminopropyl)-triethyleneglycol-
glyceryl-2-O-(2-cyanoethyl)-(N,N,-diisopropyl)-phosphoramidite
Formula: C70H106N3O11P M.W.: 1196.60 F.W.: 755.97

Diluent: 10% THF in Anhydrous Acetonitrile  40-4250-10- Please request with your order if required.


Add fresh diluent to product vial to recommended concentration and swirl vial occasionally over several minutes until product is completely dissolved. (Some oils may require between 5 and 10 minutes.) Use care to maintain anhydrous conditions. In case of transfer to alternate vial type, ensure recipient vial has been pre-dried. For more information, see http://www.glenres.com/Technical/TB_ABITransfer.pdf.

Coupling: 15 minute coupling time. To maintain label yield, carry out the synthesis DMT-on.
Deprotection: No changes needed from standard method recommended by synthesizer manufacturer. To maintain label yield, remove the 5'-DMT after ammonium hydroxide deprotection.
Storage: Freezer storage, -10 to -30°C, dry
Stability in Solution: 2-3 days

CHOLESTEROL LABELLING

Potential therapeutic oligonucleotides must permeate the cell membrane for optimal activity. The addition of lipophilic groups to an oligonucleotide would be expected to enhance activity. The use of cholesteryl oligos and the consequent improvement in activity has been described. We have designed our Cholesteryl Phosphoramidite with our branched triethyleneglycol (TEG) spacer for maximum solubility in acetonitrile as well as for applications requiring multiple labels.

 

 

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Applications & Benefits

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No. Pack
Size
Grams/
Pack
0.1M Dil.
(mL)
LV40 LV200 40nm 0.2µm 1µm 10µm
Approximate Number of Additions
10-1975-02 0.25grams .25grams 2.09 56.33 33.8 21.13 15.36 11.27 2.82
10-1975-90 100µmoles .12grams 1 20 12 7.5 5.45 4 1
10-1975-95 50µmoles .06grams .5 3.33 2 1.25 .91 .67 .17
Expedite
Cat.No. Pack
Size
Grams/
Pack
Dilution
(mL)
Molarity 50nm 0.2µm 1µm 15µm
Approximate Number of Additions
10-1975-02 0.25grams .25grams 3.12 .07 56 35 25.45 3.5
10-1975-90 100µmoles .12grams 1.5 .07 23.6 14.75 10.73 1.48
10-1975-95 50µmoles .06grams .75 .07 8.6 5.38 3.91 .54
Beckman
Cat.No. Pack
Size
Grams/
Pack
Dilution
(mL)
Molarity 30nm 200nm 1000nm

Approximate Number of Additions
10-1975-02 0.25grams .25grams 3.12 .07 57.6 36 26.18

10-1975-90 100µmoles .12grams 1.5 .07 25.2 15.75 11.45

10-1975-95 50µmoles .06grams .75 .07 10.2 6.38 4.64

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Related products

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200